Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q2 2024 Earnings Call Transcript
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q2 2024 Earnings Call Transcript August 1, 2024 Agios Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.69214 EPS, expectations were $-1.58. Operator: Good morning, and welcome to Agios’ …